secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001613103-25-000141
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q1 revenue $8.58B (+4.8% organic); raises FY26 EPS; adds 2 directors, forms new committees
--------------------------------------------------------------------------------

- Q1 GAAP EPS $0.81; non-GAAP EPS $1.26 (+2%), revenue $8.58B, organic growth 4.8%.
- FY26 non-GAAP EPS guidance raised to $5.60-$5.66 from $5.50-$5.60; organic revenue growth ~5% reaffirmed.
- Cardiac Ablation Solutions revenue +50% on pulsed field ablation strength; US +72%.
- Board expanded to 13; John Groetelaars and William Jellison appointed as independent directors.
- New Growth and Operations committees formed; Investor Day planned for mid-2026; engagement with Elliott Management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310325000141/0001613103-25-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310325000141/mdt-20250818.htm
  HTML page:      https://secwatch.observer/filing/0001613103-25-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer